Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank Value Type Network Comparison Type description green Interaction Map red Filtered network_comparison
Results: HTML CSV LaTeX Showing element 51 to 100 of 16578 in total 
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-12 subunit. [source:swissprot;acc:q9ubi6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.233\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.856\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.377\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.362\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
255.046\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
52.684\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
75.3531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
56.6768\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32952\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 1. [source:refseq;acc:nm\_017682]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
29.1831\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
37.9984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.30207\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
238.476\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
286.396\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
47.92\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-4 subunit. [source:swissprot;acc:p50150]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.191\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.863\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.328\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
75.3948\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
56.7244\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32914\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.362\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
255.046\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.26035\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 27, mitochondrial precursor (ec 1.14.-.-) (cytochrome p-450c27/25) (sterol 26-hydroxylase) (sterol 27-hydroxylase) (vitamin d(3) 25-hydroxylase) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase). [source:swissprot;acc:q02318]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
238.454\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
286.347\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
47.893\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-3 subunit. [source:swissprot;acc:p29798]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.19\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.863\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.327\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
75.3954\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
56.7252\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32913\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
thyroid receptor interacting protein 8 (trip-8) (fragment). [source:swissprot;acc:q15652]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
247.246\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
305.472\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.2355\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 24a1, mitochondrial precursor (ec 1.14.-.-) (p450- cc24) (vitamin d(3) 24-hydroxylase) (1,25-dihydroxyvitamin d(3) 24- hydroxylase) (24-ohase). [source:swissprot;acc:q07973]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.743\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
284.798\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
47.055\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-8 subunit (gamma-9). [source:swissprot;acc:q9uk08]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.184\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.864\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.32\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
75.447\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
56.7841\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32866\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
247.213\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
305.399\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.23537\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
bcl2-related ovarian killer. [source:refseq;acc:nm\_032515]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.235\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
265.638\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
42.403\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 subunit. [source:swissprot;acc:p30670]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.182\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.864\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.318\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.247\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
jumonji domain containing 1; zinc finger protein; testis-specific protein a. [source:refseq;acc:nm\_018433]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
247.169\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
305.303\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.2352\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-10 subunit. [source:swissprot;acc:p50151]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.865\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.316\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
273.188\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
40.698\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, brain form (ec 2.4.1.1). [source:swissprot;acc:p11216]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
trypsin iii precursor (ec 3.4.21.4) (brain trypsinogen) (mesotrypsinogen) (trypsin iv). [source:swissprot;acc:p35030]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
246.824\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
304.548\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.23387\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.178\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.865\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.313\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
histidine triad nucleotide-binding protein 1 (adenosine 5'- monophosphoramidase) (protein kinase c inhibitor 1) (protein kinase c- interacting protein 1) (pkci-1). [source:swissprot;acc:p49773]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.509\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
188.298\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
40.211\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, liver form (ec 2.4.1.1). [source:swissprot;acc:p06737]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
trypsin i precursor (ec 3.4.21.4) (cationic trypsinogen). [source:swissprot;acc:p07477]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
246.737\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
304.359\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.23354\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.868\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.291\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
258.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
297.273\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
38.683\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidylinositol-glycan biosynthesis, class f protein (pig-f). [source:swissprot;acc:q07326]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.21472\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
256.492\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
325.586\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.094\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
258.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
296.837\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
38.507\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
n33 protein. [source:swissprot;acc:q13454]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.21472\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
246.125\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
210.241\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
35.884\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
44\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
implantation-associated protein. [source:refseq;acc:nm\_032121]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.21472\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase. [source:refseq;acc:nm\_138335]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
282.937\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
247.202\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
35.735\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
histidine triad nucleotide-binding protein 1 (adenosine 5'- monophosphoramidase) (protein kinase c inhibitor 1) (protein kinase c- interacting protein 1) (pkci-1). [source:swissprot;acc:p49773]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.509\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
188.298\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.21355\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
282.937\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
247.202\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
35.735\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
238.476\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
286.396\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.20094\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
44\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidylinositol-glycan biosynthesis, class f protein (pig-f). [source:swissprot;acc:q07326]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
35\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/